Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysophosphatidic acid receptor 1 (LPA1R) is a G protein-coupled receptor that binds lysophosphatidic acid (LPA), a bioactive phospholipid. Upon ligand binding, LPA1R activates Gαi, Gαq, and Gα12/13 signaling pathways, regulating cell migration, proliferation, differentiation, cytoskeleton dynamics, and inflammation. LPA1R plays roles in neural development, enteric nervous system function, platelet aggregation, smooth muscle contraction, and wound healing. It is implicated in diseases such as pulmonary fibrosis, cancer, and neurodevelopmental disorders. Selective antagonists are under investigation for fibrotic diseases.
Selective antagonism of LPA1R
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysophosphatidic Acid Receptor 1 (LPA1R).